Signal active
Organization
Contact Information
Overview
Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives.
It was founded in 2008.
About
Health Care, Medical, Therapeutics
2008
51-100
Headquarters locations
Carlsbad, California, United States, North America
Social
Profile Resume
Obalon Therapeutics headquartered in United States, North America, operates in the Health Care, Medical, Therapeutics sector. The company focuses on Health Care and has secured $31.4B in funding across 156 round(s). With a team of 51-100 employees, Obalon Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Series C - Obalon Therapeutics, raised $16.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
13
3
0
$201.0M
Details
5
Obalon Therapeutics has raised a total of $201.0M in funding over 5 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2011 | Early Stage Venture | |||
2016 | Late Stage Venture | 15.8M | ||
2015 | Late Stage Venture | 20.0M | ||
2012 | Late Stage Venture | 16.5M |
Investors
Obalon Therapeutics is funded by 32 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
InterWest Partners | - | FUNDING ROUND - InterWest Partners | 16.5M |
Domain Associates | - | FUNDING ROUND - Domain Associates | 16.5M |
Obalon Therapeutics | - | FUNDING ROUND - Obalon Therapeutics | 16.5M |
Okapi Venture Capital | - | FUNDING ROUND - Okapi Venture Capital | 16.5M |
Recent Activity
News
May 25, 2024
Reuters - Obalon Reports Q1 Loss Per Share $0.71
Funding Round
Aug 06, 2019
Obalon Therapeutics raised $16600000 on 2019-08-06 in Post-IPO Equity
Funding Round
Aug 27, 2018
Obalon Therapeutics raised $10000000 on 2018-08-27 in Post-IPO Equity
Funding Round
Sep 12, 2016
Obalon Therapeutics raised $75000000 on 2016-09-12 in Post-IPO Equity
Funding Round
May 01, 2016
Obalon Therapeutics raised $15800000 on 2016-05-01 in Series E
Funding Round
Jan 14, 2015
Obalon Therapeutics raised $20000000 on 2015-01-14 in Series D